Peptency Academy · Guide
Microneedle patches for peptides: types and how they are studied
What types of microneedle patch are used for peptides, and what do studies measure?
Microneedles (MN) are the micron-scale hybrid between transdermal patches and hypodermic syringes.1 Drug Deliv Transl Res 2022 Wu and colleagues grouped microneedles into insoluble solid, hollow, soluble solid and phase transition types. Source sentence
insoluble solid microneedles, hollow microneedles, soluble/degradable solid microneedles and phase-transition microneedles2 Curr Pharm Biotechnol 2012 A polyvinyl alcohol patch with 15 by 15 microneedles held 29 ± 2 µg of semaglutide per patch. The apparent delivered amount in rat skin was 18 ± 2 µg, or 63 ± 3 percent (n = 3). Source sentence
Sema-MNs contained 29 ± 2 μg semaglutide per patch, with an apparent delivered amount of 18 ± 2 μg (63 ± 3%; n = 3)3 Int J Pharm 2026
Known, not known, contested
Known
- Microneedle designs fall into solid, coated, hollow and polymer groups. Polymer microneedles can dissolve, stay intact, or form a hydrogel. Source sentence
Multiple microneedles designs have been fabricated i.e. solid, coated, hollow, and polymer microneedles.
1 Drug Deliv Transl Res 2022 - Conventional dissolving patches load little peptide because the microneedles are small and the drug is mixed with excipients. Source sentence
dissolving MN patches are limited by low drug loading capacities due to their small size and admixture of drug and water-soluble excipients
4 Drug Deliv Transl Res 2025 - More than 90 percent of the labelled cargo left that patch within 30 minutes, and rat skin barrier function approached baseline within 4 to 6 hours. Source sentence
released more than 90% of the Sema-Cy5-associated cargo within 30 min ... skin barrier function approached baseline within 4-6 h
3 Int J Pharm 2026 - In minipigs a 7 day repeat application of the pure tip liraglutide patch caused mild erythema within 4 hours and no further irritation. Source sentence
no skin irritation was observed in minipigs except for mild erythema occurring within 4 h
4 Drug Deliv Transl Res 2025
Not known
- A PubMed search on 11 November 2026 found no study that compares one peptide in a microneedle patch with the same peptide as a lyophilised vial. Source sentence
Query run on 11 November 2026; no head to head stability comparison in the results.
5 PubMed search for peptide patch and lyophilised stability, 11 November 2026
Contested
Nothing listed yet.
- Stratum corneum
- Viable epidermis
- Dermis
- Passive patch
- Chemical permeation agent
- Iontophoresis
- Solid microneedles
- Coated microneedles
- Dissolving microneedles
- Hollow microneedles
- Hydrogel forming microneedles
Not to scale. Each route is described and cited in the list that follows.
The microneedle types
- Solid microneedles
- Solid microneedles make openings in the skin first. A formulation or patch goes on the openings afterwards. Source sentence
Solid microneedles a patch is applied after creating a hole in the skin
1 Drug Deliv Transl Res 2022 - Coated microneedles
- Coated microneedles carry the drug as a layer on the surface of the microneedle. Source sentence
Drugs are coated on the surface of Coated microneedles
1 Drug Deliv Transl Res 2022 - Dissolving microneedles
- Dissolving microneedles hold the peptide inside a polymer that dissolves in the skin. An exenatide hyaluronate patch released its load within 2 minutes in one study. Source sentence
rapidly dissolved to release encapsulated drug within 2 min
8 Pharm Res 2014 - Hollow microneedles
- Hollow microneedles carry a liquid formulation through a bore, a design close to a hypodermic but much shorter. Source sentence
Hollow microneedles are shorter in length but similar to hypodermic needles and have pore for infusion of liquid formulation of the drug.
1 Drug Deliv Transl Res 2022 - Hydrogel forming microneedles
- Hydrogel forming microneedles are a polymer class listed beside dissolving and non-dissolving types. Source sentence
Polymer microneedles can be of different types like dissolving, non-dissolving or hydrogel-forming made up of polymers.
1 Drug Deliv Transl Res 2022 - Osmotic hollow patch
- A wearable osmotic patch with three hollow microneedles released exenatide in rats and mice for 24 hours, in a study of sustained release. Source sentence
The OMN patch released the peptide drug exenatide in rats and mice for 24 hours
9 Sci Transl Med 2024
How the patches are made
- Micromold casting is the common fabrication route. One exenatide patch was cast in a micromold, and a PVA semaglutide patch was cast by vacuum assisted molding followed by drying at room temperature. Source sentence
prepared semaglutide-loaded poly(vinyl alcohol) (PVA) dissolving microneedles (Sema-MNs) by sequential vacuum-assisted molding and room-temperature drying
3 Int J Pharm 20268 Pharm Res 2014 - A hyaluronic acid and aminoclay patch was poured into a negative polydimethylsiloxane mold, and a teriparatide patch was made by centrifugal lithography in two layers. Source sentence
poured into a reverse polydimethylsiloxane (PDMS) mold to create dissolving microneedles
10 Int J Nanomedicine 202511 Polymers 2022 - Two layer designs keep the peptide in the tip. The teriparatide patch had a pure hyaluronic acid base layer and a peptide polymer top layer, and 87.6 percent of the peptide reached porcine skin after 5 minutes. Source sentence
dried pure hyaluronic acid on the base layer and dried TA polymer solution on the top layer ... 87.6% of TA was delivered to the porcine skin after a 5-min TA-DMN patch application
11 Polymers 2022 - A stratified exenatide patch put a dextran and zinc complex in the tip and polyvinyl alcohol in the base. Source sentence
a tip layer (dextran encapsulating the Zn2+-EXT complex) and a base layer (PVA)
12 Int J Pharm 2023
Loading, strength and what reaches the skin
- Conventional dissolving patches load little peptide because the microneedles are small and the drug is mixed with excipients. Source sentence
dissolving MN patches are limited by low drug loading capacities due to their small size and admixture of drug and water-soluble excipients
4 Drug Deliv Transl Res 2025 - A liraglutide patch with pure drug tips loaded up to 2.21 ± 0.14 mg in 0.9 cm², nearly two orders of magnitude more than conventional dissolving patches of the same size. Source sentence
The MN patch could load up to 2.21 ± 0.14 mg of liraglutide in a patch size of 0.9 cm2, which was nearly two orders of magnitude higher than that obtained with conventional MN patches of the same size.
4 Drug Deliv Transl Res 2025 - Fracture force per microneedle is a standard mechanical readout: 3.47 N in one semaglutide patch and 0.37 N in another. Source sentence
robust mechanical strength (3.47 N/needle; fracture force)
13 AAPS PharmSciTech 202610 Int J Nanomedicine 2025 - A polyvinyl alcohol patch with 15 by 15 microneedles held 29 ± 2 µg of semaglutide per patch. The apparent delivered amount in rat skin was 18 ± 2 µg, or 63 ± 3 percent (n = 3). Source sentence
Sema-MNs contained 29 ± 2 μg semaglutide per patch, with an apparent delivered amount of 18 ± 2 μg (63 ± 3%; n = 3)
3 Int J Pharm 2026 - More than 90 percent of the labelled cargo left that patch within 30 minutes, and rat skin barrier function approached baseline within 4 to 6 hours. Source sentence
released more than 90% of the Sema-Cy5-associated cargo within 30 min ... skin barrier function approached baseline within 4-6 h
3 Int J Pharm 2026
What happens to the skin
- An exenatide hyaluronate patch kept the peptide's activity through fabrication and one month of storage. Skin barrier function recovered within 10 to 12 hours. Source sentence
The EXT preserved its pharmacological activity during fabrication and one-month storage. ... skin's barrier properties disrupted by MNs recovered within 10-12 h.
8 Pharm Res 2014 - In minipigs a 7 day repeat application of the pure tip liraglutide patch caused mild erythema within 4 hours and no further irritation. Source sentence
no skin irritation was observed in minipigs except for mild erythema occurring within 4 h
4 Drug Deliv Transl Res 2025
Peptides that reached human studies
- A coated microneedle patch of parathyroid hormone (1-34) was studied in phase 1 for application site, wear time and amount, then in phase 2 against a placebo patch and a parenteral reference. Source sentence
Abstract, methods: phase 1 pharmacokinetic studies varied application site, wear time and amount in volunteers aged 40 to 85; phase 2 compared patch levels with a placebo patch and a reference product.
14 Pharm Res 2011 - An abaloparatide solid microstructured transdermal system reached phase 1b in 22 postmenopausal participants, with systemic exposure as the primary endpoint. Median time to peak on day 1 was 0.33 hours. Source sentence
The primary endpoint was systemic exposure to abaloparatide ... the median time to reach maximum concentration (Tmax) for abaloparatide-sMTS was 0.33 h
15 Clin Drug Investig 2021 - Salmon calcitonin dissolving arrays reached about 70 percent relative bioavailability in a pharmacodynamic study. Source sentence
DMNA patch could significantly enhanced relative bioavailability to approximately 70%
16 AAPS PharmSciTech 2020 - A weekly teriparatide dissolving patch reached 66.9 percent relative bioavailability in rats. Source sentence
The relative bioavailability of TA via subcutaneous injection was 66.9% in rats treated with TA-DMN patches.
11 Polymers 2022
What is a dissolving microneedle patch?
rapidly dissolved to release encapsulated drug within 2 min8 Pharm Res 201413 AAPS PharmSciTech 2026
How long are microneedles?
Dissolving MN arrays containing 196 needles (600 μm needle height)17 Int J Pharm 201613 AAPS PharmSciTech 2026
Is a microneedle patch the same as a microneedling roller?
FDA page: microneedling devices for aesthetic use are Class II.18 FDA, Microneedling devices page
Published examples with IDs
In vitro or ex vivoAAPS PharmSciTech 2026
Fracture force, Parafilm insertion depth, release over 12 hours and ex vivo porcine skin insertion
- Design
- Formulation and characterisation of dissolving microneedles with hyaluronic acid, PETOX and L-arginine
- Population or model
- Parafilm M, porcine skin ex vivo
- Molecule
- Semaglutide exact
RodentInternational journal of pharmaceutics 2026
Loading per patch, apparent delivered amount, release within 30 minutes and skin barrier recovery
- Design
- Polyvinyl alcohol dissolving microneedles made by vacuum assisted molding, tested in rat skin
- Population or model
- Rats
- Molecule
- Semaglutide exact
- n
- 3
- Comparator
- Unloaded microneedle controls
RodentInternational journal of nanomedicine 2025
Fracture force of 0.37 N per microneedle, stability at 25 °C and systemic exposure versus free drug microneedles
- Design
- Hyaluronic acid and aminoclay nanocomposite microneedles tested for strength, storage stability and exposure in rats
- Population or model
- Rats
- Molecule
- Semaglutide exact
RodentDrug delivery and translational research 2025
Loading up to 2.21 mg per 0.9 cm², delivered amount, relative bioavailability and local skin response
- Design
- Dissolving microneedle patch with pure drug tips, pharmacokinetics in rats and minipigs
- Population or model
- Rats and minipigs
- Molecule
- Liraglutide related form
RodentPharmaceutical research 2014
Dissolution within 2 minutes, skin barrier recovery in 10 to 12 hours and activity after one month of storage
- Design
- Hyaluronate dissolving microneedles: strength, insertion, dissolution, storage and exposure
- Population or model
- Rats
- Molecule
- Exenatide related form
- Duration
- 1 month storage
RodentInternational journal of pharmaceutics 2023
Retained exenatide after 9 weeks at high temperature and 3 months at 40 °C and -20 °C
- Design
- Stratified dissolving microneedles with dextran, polyvinyl alcohol and zinc, stored at high temperature
- Population or model
- Rats
- Molecule
- Exenatide related form
- Duration
- 9 weeks and 3 months
RodentPolymers 2022
Delivery into porcine skin after 5 minutes and relative bioavailability in rats
- Design
- Two layer teriparatide dissolving microneedle patch made by centrifugal lithography
- Population or model
- Porcine skin ex vivo, rats
- Molecule
- Teriparatide related form
Analytical only (no biological model)International journal of pharmaceutics 2016
Release of model cargos from 196 microneedle arrays over 6 hours
- Design
- Parafilm M pouch release test compared with Franz cell methodology for dissolving arrays
- Population or model
- Parafilm M membrane
- Molecule
- Model cargos not established
Sources
- 1Drug Deliv Transl Res 2022 accessed 11 Nov 2026
- 2Curr Pharm Biotechnol 2012 accessed 11 Nov 2026
- 3Int J Pharm 2026 accessed 11 Nov 2026
- 4Drug Deliv Transl Res 2025 accessed 11 Nov 2026
- 5PubMed search for peptide patch and lyophilised stability, 11 November 2026 accessed 11 Nov 2026
- 6Nat Biotechnol 2008 accessed 11 Nov 2026
- 7Adv Drug Deliv Rev 2004 accessed 11 Nov 2026
- 8Pharm Res 2014 accessed 11 Nov 2026
- 9Sci Transl Med 2024 accessed 11 Nov 2026
- 10Int J Nanomedicine 2025 accessed 11 Nov 2026
- 11Polymers 2022 accessed 11 Nov 2026
- 12Int J Pharm 2023 accessed 11 Nov 2026
- 13AAPS PharmSciTech 2026 accessed 11 Nov 2026
- 14Pharm Res 2011 accessed 11 Nov 2026
- 15Clin Drug Investig 2021 accessed 11 Nov 2026
- 16AAPS PharmSciTech 2020 accessed 11 Nov 2026
- 17Int J Pharm 2016 accessed 11 Nov 2026
- 18FDA, Microneedling devices page accessed 11 Nov 2026
About this page
Research-use information. This library summarises published literature and regulator records. It is not guidance for use, not medical advice, and not a statement that any material is suitable for use in people or animals.
Reviewed by the Peptency editorial process. Version 1, edited 11 November 2026, 18 sources.
Cite this page: Peptency Academy. Microneedle patches for peptides: types and how they are studied. Version 1./eu/academy/guides/microneedle-patches-for-peptides/